Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

453.486
-12.837-2.75%
Number of Gainers:8
Number of Losers:38
Number of Flat:5
PE:- -
High:466.335
Open:466.335
Low:452.923
Close:466.322
Volume:443.82M
Turnover:11.07B
Market Cap:2.87T
Float Cap:1.99T

Loading ...

China Resources Mixc Lifestyle Services Stock Sheds 2.4% in Hong Kong

Dow Jones
·
7 hours ago

Hansoh Pharmaceutical Group Stock Falls 4.2% in Hong Kong

Dow Jones
·
7 hours ago

AH Share Premium Rankings: September 10 Market Close Update

Stock News
·
7 hours ago

China United Insurance Accelerates Asset Management License Push, Poised to Become 39th Insurance AMC

Deep News
·
7 hours ago

Haidilao Co-Founder's Wife Cashes Out $3.1 Billion Amid New Offshore Trust Tax Rules

Deep News
·
9 hours ago

Hotpot Chain Founder's Wife Cashes Out $2.4 Billion in Share Sale

Deep News
·
9 hours ago

Jinxin Fertility Plans Women's Health-Focused Translational Medicine Platform

MT Newswires Live
·
10 hours ago

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

Stock News
·
12 hours ago

Morgan Stanley Suggests Market Misreads Li Ning's Decline Linked to Haidilao Shareholder Move

Deep News
·
13 hours ago

Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform

Stock News
·
14 hours ago

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

Stock News
·
15 hours ago

AK Medical Sets Dividend Payout Floor at 55% for Fy2026, 60% for Fy2027-28

Reuters
·
17 hours ago

AK Medical - Announces Fy2027 and Fy2028 Dividend Payout Ratio Increased to not Less than 60%

THOMSON REUTERS
·
17 hours ago

AK Medical - Announces Fy2026 Dividend Payout Ratio Increased to not Less than 55%

THOMSON REUTERS
·
17 hours ago

Haidilao's Corporate Shift to Digitized Management Signals Waning Store-Centric Narrative

Deep News
·
Yesterday

Hbm Holdings Says Solstice Oncology Launches Series a Financing Round

Reuters
·
Yesterday

Lee's Pharm Secures Exclusive Rights to Develop and Market Novel PARP1 Inhibitor Across Greater China and Southeast Asia

Stock News
·
Yesterday

Shandong Boan Biotech Confirms RMB 75 Million Finance Lease Asset Sale Price in Supplemental Pact

Reuters
·
Yesterday

Everest Medicines Unit Enters Supply, Distribution Cooperation Contract

MT Newswires Live
·
Yesterday

SUNAC SERVICES Spends Nearly HK$164,000 to Buy Back 200,000 Shares

Stock News
·
Yesterday